Inhibiting transmission of Plasmodium is an essential strategy in malaria eradication, and the biological process of gamete fusion during fertilization is a proven target for this approach. Lack of knowledge of the mechanisms underlying fertilization have been a hindrance in the development of transmissionblocking interventions. Here we describe a protein disulphide isomerase essential for malarial transmission (PDI-Trans/PBANKA_0820300) to the mosquito. We show that PDI-Trans activity is malespecific, surface-expressed, essential for fertilization/transmission, and exhibits disulphide isomerase activity which is up-regulated post-gamete activation. We demonstrate that PDI-Trans is a viable antimalarial drug and vaccine target blocking malarial transmission with the use of PDI inhibitor bacitracin (98.21%/92.48% reduction in intensity/prevalence), and anti-PDI-Trans antibodies (66.22%/33.16% reduction in intensity/prevalence). To our knowledge, these results provide the first evidence that PDI function is essential for malarial transmission, and emphasize the potential of anti-PDI agents to act as anti-malarials, facilitating the future development of novel transmission-blocking interventions.
Malaria remains a significant widespread health challenge with an estimated 216 million cases and 435,000 deaths globally in 2017 1 . Recent approaches have significantly reduced global burden but recent progress has stalled 1 , and it is widely accepted that a range of new tools will be required to attain malaria elimination 2 . The causative agent of malaria, the protozoan parasite Plasmodium, is transmitted almost exclusively by anopheline mosquitoes. Transmission of Plasmodium from vertebrate to mosquito hosts is entirely dependent on the circulation of sexually viable gametocytes within circulating blood, which differentiate into micro-(male) and macro-(female) gametes upon ingestion by the mosquito within a blood meal. The essential process of fertilization is a two stage process, initiated by gamete adhesion, followed by membrane fusion 3, 4 . A small number of proteins have previously been implicated in plasmodial fertilization; the 6-Cys protein family members P48/45, P47 and P230 have demonstrable roles in the mutual recognition and adhesion of micro-and macro-gametes [5] [6] [7] , whereas the conserved male-specific Class II fusion protein HAP2/GCS1 has been shown to be the key driver of membrane fusion by mediating merger of lipid bilayers 3, 4 . Following successful fertilization, resulting zygotes develop into ookinetes, which migrate to and invade the mosquito midgut, establishing infection in the insect. Despite the key importance of parasitic transmission and its undoubted potential as a point to disrupt the plasmodial lifecycle with various therapeutic classes 8 , our knowledge of the mechanisms underlying fertilization and subsequent zygote formation in Plasmodium is surprisingly incomplete.
It is recognized that to achieve malarial control or eradication, it is vital to use interventions that inhibit transmission from humans to mosquitoes 2 . A potential mechanism to achieve this is to target Plasmodium using transmission-blocking interventions (TBIs); i.e. transmission blocking vaccines (TBVs), or transmission blocking drugs (TBDs) against parasitic sexual stages [9] [10] [11] . Antibodies targeting three of the five currently proven, potent TBV targets (P48/45, P230, HAP2) have demonstrable localization to proteins found on the plasma membrane of the gametes [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] , indicating the potential value of targeting this lifecycle stage 21 . Additionally, multiple anti-malarial compounds have been demonstrated to have activity against this parasitic stage [23] [24] [25] [26] [27] . In summary, the comparatively short life span, fragility, and availability of proteins on the surface of the Plasmodium male gamete make targeting this stage of the lifecycle a potential method of impeding transmission 11, 27 . Similarly, potent TBIs targeting the parasitic ookinete post-fertilization are well characterized in multiple vaccine and drug studies 10, 17, 18, [28] [29] [30] .
Protein Disulphide Isomerase (PDI) (EC: 5.3.4.1) is a multifunctional member of the thioredoxin superfamily of redox proteins, characterized by the presence of the βαβαβαββα fold 31 . PDIs typically have three catalytic activities; disulphide isomerase, thiol-disulphide oxidoreductase, and redox-dependent chaperone. PDI homologues have been identified in multiple species, where they are "classically" located in the endoplasmic reticulum (ER) and facilitate the folding and assembly of secretory and membrane proteins within the lumen 32 . In Plasmodium, a small number of proteins have been putatively identified (by sequence homology) as PDI-like molecules in Plasmodium falciparum, vivax, knowlesi, berghei and yoelii [33] [34] [35] . Conclusive demonstration of PDI activity has currently only been demonstrated with PF3D7_0827900/PDI-8 33 , with transcription and translation demonstrated in asexual blood schizonts, gametocytes and sporozoites. Knowledge regarding the process of disulphide bond-dependent protein folding in Plasmodium is scarce.
Similarly, an increased understanding of transmission and mechanisms of fertilization within Plasmodium is vital, and offers prospective opportunities for the development of novel TBIs. Here, we describe the identification, characterization and role of a protein disulphide isomerase (PDI-Trans/PBANKA_0820300) essential for malarial transmission to the mosquito host in P. berghei. We demonstrate that PDI-Trans is transcribed and translated across the entire parasitic lifecycle, and exhibits activity at the sexual stages of the lifecycle, when fertilization of gametes occurs. We show that PDI-Trans function is male specific after microgamete release, and essential for successful fertilization/transmission, and exhibits disulphide isomerase function which is up-regulated post-gamete activation. Furthermore, we show that PDI-Trans is a viable anti-malarial drug and vaccine target, expressed on the surface of the sexual stages of Plasmodium, by blocking malarial transmission with the use of repurposed compounds that target PDI activity, and anti-PDI-Trans peptide antibodies. These results demonstrate that protein disulphide isomerase function is essential for malarial transmission; emphasize the potential of anti-PDI agents to act as anti-malarials, and demonstrate the potential utility of rationally-selected targets to facilitate the development of novel anti-malarial transmission-blocking interventions.
Results

PDI-Trans is located on the surface on the transmission stages of P. berghei. Previous proteomic
analysis of a P. berghei male gamete proteome generated in [36] [37] [38] followed by advanced bioinformatics analysis encompassing a suite of functional and localization-based algorithms 36 identified the expression of PDI-Trans (PBANKA_0820300) in the male gamete, and suggested that the resulting transmembrane protein was potentially located on the surface of the plasma membrane of male gametes. A brief analysis of PDI-Trans is described within 39 , where following a BarSeq Screen for asexual growth on an extensive library of non-clonal P. berghei KO parasites, posited that the gene is dispensable for the progression of blood-stage parasitemia. Our subsequent analysis of transcription levels by RT-PCR support this, demonstrating that PDI-Trans transcripts were present in wild-type asexual erythrocytic stages of the gametocyte the deficient strain 2.33, in addition to non-activated (Gc−) and activated (Gc+) gametocytes, ookinetes and sporozoites of the parental line 2.34 ( Fig. 1A) . To investigate the cellular localization of PDI-Trans across the parasitic lifecycle targeted-single homologous recombination was utilized to generate a transgenic P. berghei parasite expressing the endogenous PDI-Trans protein with a C-terminal EGFP fusion tag. Successful integration following drug selection was confirmed by PCR ( Fig. 1B) . The presence of the EGFP tag caused no observable impact on blood or sexual stages, and did not impact transmission through An. stephensi mosquitoes. Immunofluorescence microscopy on non-permeablized parasites confirmed PDI-Trans-GFP expression at the surface of activated male gametes and ookinetes (Fig. 1C ). Live microscopy of mixed blood stages, female gametes and fixed immunofluorescence of sporozoites demonstrated that PDI-Trans-GFP is expressed across the entire parasitic lifecycle ( Figure S1 ).
PDI-Trans is essential for parasite transmission, is male specific and demonstrates classical PDI activity.
To investigate the function of PDI-Trans targeted gene disruption was used to replace the entire PDI-Trans coding sequence. This was performed by double homologous recombination as described in 39, 40 , with constructs designed and manufactured by PlasmoGem (Sanger Institute, UK). Following dilution cloning of drug-resistant parasites, genotyping by PCR of two independently produced clones ( Fig. 2A) indicates that the replacement construct had integrated at the targeted site, disrupting the endogenous locus. Consistent with previous predictions 40, 41 , examination of mice infected with ΔPDI-Trans clones showed that the parasites underwent normal asexual development in erythrocytes ( Figure S2 ). Rates of gametocytogenesis and sex ratio were unaffected, and gametocytes were able to emerge from their host cells and differentiate into gametes when exposed to standard gamete activation conditions (i.e. drop in pH or temperature, presence of xanthaurenic acid). To examine non-inactivated gametes, incubation in coelenterazine loading buffer followed by Nycodenz purification was performed 42 . To examine for a specific role during fertilization we specifically examined in vitro ookinete formation in blood collected from mice infected with ΔPDI-Trans parasites. Blood cultures from mice infected with ΔPDI-Trans parasites failed to produce ookinetes, a finding confirmed by triplicate experiments on two independent ΔPDI-Trans clones (Fig. 2B ). To further explore this phenotype in vivo, An. stephensi mosquitoes were fed on mice infected with ΔPDI-Trans parasites in triplicate studies, and 12 days later microscopy was used to examine the presence of oocysts ( Figure S3 ). Triplicate experiments of each clone showed a mean reduction of 94.38% inhibition in intensity and 63.68% inhibition in oocyst prevalence with in ΔPDI-Trans clone 1, and a 96.43%/65.62% inhibition in intensity/prevalence with ΔPDI-Trans clone 2 when compared to wild type P. berghei ( Table 1 ). The phenomenon of total blockade in transmission in vitro, while still observing low levels in vivo, is often observed with fertilization-null phenotypes following gene deletion (e.g. following KOs of HAP2 and www.nature.com/scientificreports www.nature.com/scientificreports/ Malarial fertilization is inhibited reversibly by the PDI inhibitor Bacitracin in vitro. To further explore PDI-Trans activity, and to examine the ability of specific PDI inhibitors to block malarial transmission, we utilized the classical PDI inhibitor bacitracin 44 . The peptide antibiotic bacitracin was first reported to be an inhibitor of PDI in 1981 45 , and has subsequently been used in a wide range of studies to demonstrate the role of PDI in cellular processes, including glioma cell invasion 46 , melanoma cell death 47 , viral entry 48, 49 , and platelet function 50 . Subsequent experimentation has demonstrated direct interaction of PDI with bacitracin, resulting in disulfide bond formation between an open thiol of the bacitracin thiazoline ring, and corresponding cysteines within the substrate-binding domain of PDI 51 . Bacitracin has proven low membrane permeability 51 , giving it utility as a tool to assess PDI-dependent cell-surface reductase activity 52 . In vitro addition of bacitracin pre-fertilization resulted in a dose-dependent reduction of exflagellation centres (defined as motile flagellate male gametes bound to at least three additional cells), with a complete inhibition in formation of exflagellation centers at 3 mM ( Fig. 3A) . This subsequently inhibited the ability of gametocytes to form ookinetes, with complete inhibition of ookinete conversion at 3 mM bacitracin ( Fig. 3B) . In order to test whether bacitracin has a broad and non-specific toxic effect on parasites, potentially unrelated to PDI-Trans function, gametocytes were pre-incubated in bacitracin at a range of concentrations for 30 minutes, washed to remove the PDI inhibitor, then assayed for formation of exflagellation centers/ookinetes respectively (post-wash). Results show that parasites pre-incubated with bacitracin, then washed, resulted in no detectable reduction (Paired t test) in the number of exflagellation centres compared to the untreated control across all concentrations examined ( Fig. 3C,D) .
In an attempt to further examine the activity of PDI-Trans and the mechanism of PDI-inhibitor based blockade of transmission, following bacitracin treatment we examined the number of visible free floating male gametes present, compared with the number of exflagellation centers present (rosettes comprising the adherence of newly emerged microgametes adhering to neighboring erythrocytes, defined as a motile male gamete adhered to three cells). As bacitracin concentrations increased. the number of visible exflagellation centres decreased, conversely, the number of free floating observed microgametes was unaffected ( Fig. 3E ), suggesting that PDI activity is essential for the association of male gametes to additional cells to form exflagellation centers, but not for the ability of gametogenesis/activation to form microgametes.
Malarial transmission is inhibited by Bacitracin in P. berghei and P. falciparum.
To test the ability of bacitracin to block the transmission of P. berghei ex vivo we performed standard membrane feeding assays (SMFA) in triplicate with 0.3, 1 and 3 mM doses of bacitracin ( Fig. 4A -C). Bacitracin inhibited transmission at all concentrations in a dose-dependent manner with a maximum inhibition in oocyst intensity of 98.21% and infection prevalence of 92.48% with 3 mM bacitracin ( Table 2) .
To investigate if PDI function is implicated in fertilization in additional Plasmodium species, and to extend our observations in P. berghei to human malaria parasites, we performed SMFAs with P. falciparum gametocyte cultures in the presence of bacitracin. Given the results observed with P. berghei we chose to perform the P. falciparum feeds at the highest concentration of bacitracin (3 mM) in triplicate to detect maximal effect ( Fig. 4D-F ). The addition of bacitracin significantly inhibited transmission, with a mean inhibition in oocyst intensity of 95.05% and an inhibition of oocyst prevalence of 81.71% observed (Table 3) .
PDI-Trans can be targeted specifically with antibodies to block transmission in vitro and ex vivo. Activity of the membrane impermeant 53 drug Bacitracin and localization strongly suggest PDI-Trans
is located on the surface of the microgamete and ookinete, therefore the ability of anti-PDI-Trans antibodies to initiate a specific anti-parasitic transmission blocking response was additionally examined. A polyclonal anti-peptide antibody was raised against residues bioinformatically predicted to be within the extracellular domain of PDI-Trans (amino acids [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] . Antibodies were raised in rabbits, IgG purified, and examined for their ability to inhibit transmission in vitro and ex vivo. Anti-PDI-Trans IgG recognized both non-permeabilized gametocytes and ookinetes by IFA ( Fig. 5A ). Staining was absent in secondary only controls Fig. 5B ), and on activated ΔPDI-Trans male gametes (Fig. 5C ) indicating the ability of these antibodies to specifically recognize natively folded PDI-Trans on the gamete and ookinete surface.
To examine the ability of PDI-Trans to act a transmission blocking antigen, in vitro ookinete conversion assays were perfumed in the presence of anti-PDI-Trans. Anti-PDI-Trans inhibited ookinete conversion in a dose-dependent manner, further suggesting specificity. At antibody concentrations of 50, 100, 250 and 500 μg/ ml, ookinete formation was inhibited by 14.3%, 33.2%, 38.7% and 75.4% respectively. In contrast, as previously demonstrated 4 , the presence of the isotypic IgG UPC10 (negative control) had no discernable effect on ookinete conversion (Fig. 5D ). www.nature.com/scientificreports www.nature.com/scientificreports/ Anti-PDI-Trans antibodies significantly inhibited P. berghei transmission in all experiments. At a concentration of 500 μg/ml anti-PDI-Trans antibodies inhibited oocyst intensity by a mean of 66.22% and reduced prevalence of infection by 33.16% (Table 4 ).
Wild type
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Discussion
Fertilization is a key process in the Plasmodium lifecycle, encompassing the active fusion of activated male (micro) and female (macro) gametes to form a zygote within the mosquito bloodmeal. Despite its essential nature to the success of the parasitic lifecycle, the cellular and molecular mechanisms that underlie fertilization remain largely opaque. Merely three proteins have been discovered that have a perceptible role in the mutual recognition of Plasmodium gametes; the 6-Cys family members, P48/45, P47 and P230 5 . The specific mechanism of action of these proteins are currently unknown. Following gamete recognition, the plasma membranes of the male and female gametes come into intimate contact and fuse, resulting in cytoplasmic continuity. The conserved class II fusion protein HAP2 is essential for gamete fusion during fertilization, and initiates merger of lipid bilayers post gamete adhesion. Following a (currently unidentified) trigger, it is postulated that a short-conserved region within the Plasmodium HAP2 ectodomain becomes exposed on the microgamete membrane surface, leading to the subsequent parallel trimerization of protein subunits 4, 54, 55 . Polar residues within this "fusion loop" are subsequently inserted into the macrogamete membrane, followed by a conformational change in HAP2 domain III which distorts the target membrane, causing hemifusion followed by fusion/cytoplasmic continuity. Further related upstream and downstream effector molecules that specifically mediate the process of fertilization are at present unclear.
Here, we demonstrate that protein disulphide isomerase function, specifically encoded by a single plasmodial gene (PDI-Trans/PBANKA_0820300) is essential for malarial transmission. We demonstrate that PDI-Trans is constitutively expressed throughout the parasitic lifecycle, in both the blood and mosquito stages, but is only essential in the male gamete. This is consistent with transcriptomic data described in 55 , where transcripts of PBANKA_082030 have demonstrated upregulation in male gametes. Absence of PDI-Trans only confers a detectable effect post-gamete activation, prior to gamete adhesion, and is null for male fertility, and consequently, zygote/ookinete formation, and transmission to the mosquito host. Complementation of the disrupted locus restores fertility. Furthermore, we demonstrate reductase activity, indicative of classical PDI activity. Inhibition of PDI-Trans using the widely available (topical) antibiotic and PDI inhibitor, bacitracin, reversibly blocks plasmodial transmission in vivo and ex vivo. Specifically, the process of gamete activation remains unaffected by bacitracin, whereas the ability of treated gametes to adhere to other cells (i.e. form exflagellation centers) appears to be compromised. Bacitracin-derived transmission blockade is observed in both P. berghei and P. falciparum. Finally, we show that antibodies specifically raised against the extracellular region of PDI-Trans can recognize the surface of the sexual stages of the parasite by immunofluorescence, and can initiate transmission-blocking activity both in vitro and ex vivo.
In all living cells, the appropriate formation and cleavage of disulphide bonds between cysteine residues in secreted and membrane anchored proteins is essential for native conformation, and therefore, function. PDIs are traditionally known to be versatile enzymes with key roles in the mediation of disulfide bond formation, isomeration and reduction in the endoplasmic reticulum 33 . PDI function is also associated with varied chaperone activity 32 . Little is known regarding the expression and function of PDI-like proteins in Plasmodium. A previous study 34 has bioinformatically identified nine PDI-like molecules across five species of malaria parasites (four in falciparum, one in vivax, berghei, knowlesi and yoelii), indicated by the presence of classical thioredoxin domains. A more detailed analysis of one of these PDI candidates in P. falciparum; PfPDI-8 (PF3D7_0827900), demonstrated expression within the endoplasmic reticulum of asexual blood schizonts, gametocytes and sporozoites, with biochemical analysis indicating a function in the disulfide-dependent conformational folding of a recombinant form of the erythrocyte-binding protein (and putative bloodstage vaccine target) EBA-175. As further evidence of the chaperone function of PDI enzymes, studies utilizing the overexpression of PfPDI-8 resulted in the enhanced expression and folding of the transmission-blocking vaccine candidate, Pfs25, in a Picha pastoris expression system 56 . Broadly, PDI function is bioinformatically predicted to be conferred by multiple ORF throughout the parasitic genome, with recent bioinformatics predictions (PlasmoDB) suggesting the presence of six PDI-related ORFs in P. berghei (with homologues in P. falciparum). Expression, localization and function of these proteins are still largely undefined. Future study to further dissect the function of PDIs (and associated mechanisms of protein folding) in Plasmodium may be advantageous.
Although classically considered to be key mediators of protein folding in the endoplasmic reticulum, key evidence showing localization and function of PDIs in other cell compartments does exist. In some organisms, PDIs have been demonstrated to on occasion escape the ER, and exhibit cytoplasmic and cell surface localization, where their predominant function appears to be the reduction of disulphide bonds 33, 57 . In terms of fertilization, PDI activity on the sperm head has previously proved to be essential for sperm-egg cell fusion in multiple vertebrates 32, [58] [59] [60] , and implicated in male fertility in mice 61, 62 . PDI function has previously been implicated in the progression of multiple infectious diseases, with a specific role in mediating pathogen entry. In viruses, overexpression of PDI enhances the fusion of vial membranes, leading to increased internalization of HIV-1 63 . Cell surface PDI has been shown to facilitate the infection of HeLa cells by mouse polyoma virus 64 , and in endothelial cells a surface localized (lipid-raft associated) PDI reduces β1 and β2 integrins, allowing for the entry of dengue virus 52, 65 . Its function is also essential for release of cholera toxin active chain A from the ER to the cytosol of the infected cell 66 . In protozoan pathogens, previous experimentation has demonstrated that increased levels of PDI enhance phagocytosis of the L. chagasi promastigote (but not the amastigote) 67 . It has previously been hypothesized that T. gondii and L. donovani PDI could be putative targets for vaccine development 68, 69 . The specific function of PDI-Trans in the parasite is still unknown, however, it is clear that successful fertilization in Plasmodium requires the presence and function of a range of proteins with conserved disulphide bonds between cysteine Table 4 . Mean ex vivo evaluation of transmission blocking effect of anti-PDI-Trans antibodies. The mean (from three replicates) change in intensity (mean number of oocysts per midgut) and prevalence with anti PDI-Trans antibody at 500 µg/ml were calculated with respect to appropriate negative control antibody UPC10 at the same concentration. a P < 0.05, Mann-Whitney U test b P < 0.05, Fisher's exact test.
rearrangement in one of these transmission-essential proteins, exposing key residues critical for fertility-based function.
The results described here clearly indicate that PDI-Trans is a potential target for anti-malarial strategies to successfully inhibit malarial transmission. The generation of novel TBIs to reduce disease burden is a key component of the current anti-malarial strategy, and it is accepted that to achieve eradication, it will be hugely advantageous to use interventions that inhibit transmission of parasites from humans to mosquitoes 2 . We demonstrate that bacitracin reversibly inhibits malarial transmission with high efficacy, and additionally, that antibodies targeting PDI-Trans mediate significant transmission reducing immunity. It should be noted that bacitracin is already an FDA approved compound, traditionally used clinically against gram-positive bacteria. This example illustrates the potential value of re-purposing drugs with observed efficacy against non-malarial species. Previous studies examining the anti-malarial efficacy of bacitracin only examined impact on asexual growth, where no effect was demonstrated 70 . The data here provides further evidence that anti-malarial transmission blocking efficacy can be achieved by targeting the male/micro gamete. Previously described compounds effective against the process of fertilization (methylene blue and atovaquone) are effective in blocking transmission, as are antibodies against multiple male gamete-surface proteins [22] [23] [24] . A deeper understanding of transmission and the mechanisms of fertilization within Plasmodium will be advantageous to develop novel interventions in the future. More broadly, PDI-like proteins are expressed across multiple species and taxa, including in a range of pathogens of veterinary and clinical importance 30, 31, 48 . Given the ability of both anti-PDI-Trans compounds and antibodies to inhibit malarial transmission described here, and the proven role of PDI function in the regulation of infection across multiple species, it is logical to suggest that future studies may want to examine the possibility of targeting PDI proteins/functions using specifically designed novel anti-malarial drugs or vaccines.
Materials and Methods
General parasite maintenance. Parasite maintenance was carried out as described in 71 . P. berghei was maintained in ~6 week-old female TO mice (Harlan)ƒ. If necessary, hyper-reticulosis was induced three days pre-infection by treating intraperitoneally (i.p) with 200 μl phenylhydrazinium chloride (PH; 6 mg/ml; ProLabo). Infections were monitored via Giemsa-stained thin smears as described previously 43 .
Purification of gametocytes. Purification of gametocytes was achieved using a protocol modified from 7 .
Mice were treated i.p with 200 μl phenylhydrazinium chloride (PH; 6 mg/ml in PBS; ProLabo UK). Day four post infection (p.i.) mice were treated with sulfadiazine (Sigma) at 20 mg/L in their drinking water for two days to eliminate asexual blood stage parasites. On day six p.i. mice were bled by cardiac puncture into heparin and gametocytes separated from uninfected erythrocytes on a 48% NycoDenz gradient (27. Generation and analysis of transgenic parasite lines. PDI-Trans-GFP. To examine the expression and localization of PDI-Trans, the PDI-Trans-GFP transgenic line was created, introducing a C-terminal GFP tag to the native protein by single homologous recombination. The targeting construct pPDI-Trans-GFP was produced using the backbone of the EGFP-tagging vector p277 72 . The terminal 1527 bp of the PDI gene (PBANKA_082030) was synthesized to remove an internal ApaI site and introduce unique AvrII site within the gene and flanking KpnI and ApaI sites to the amplicon. This block was cloned in frame into ApaI/KpnI sites of p277, resulting in pPDI-Trans -GFP. For transfection, this construct was linearized at a unique AvrII site within the PDI sequence.
Parasites were transfected using the Nucleofector device (Amaxa Biosystems) as described previously 65 . Integration of the DNA constructs into the chromosome was confirmed by PCR flanking a region upstream from the 5′ integration site into the EGFP sequence (oligo 35; 5′-GCATGTGCGATTGTATTGGG-3; oligo 14; 5′-ACGCTGAACTTGTGGCCG-3′) and the presence of the DHFR selection cassette (oligo 91 5′-TTCGCTAAACTGCATCGT -3′; oligo 92 5′-GTACTTAATGCCTTTCTCCT-3′). Oligos against the Pbs25 gene (PBANKA_0051500) were used as positive control (oligos F1: 5′-CAACTTAGCATAAATATAATAATGCGAAAGTTACCGTGG-3′; F2 5′-CCATCTTTACAATCACATTTATAAATTCCATC-3′). GFP expression in transfected, drug resistant parasites were confirmed by fluorescence microscopy. Two independent clones were obtained from two independent transfections, demonstrating identical phenotypes and GFP expression.
ΔPDI-Trans.
To examine the function of PBANKA_082030 the ΔPDI-Trans transgenic line was generated. The plasmid was designed and constructed by PlasmoGEM (PlasmoGem ID PbGEM-239637) using recombinase-mediated engineering followed by a Gateway ® mediated exchange 41, 73 . Prior to transfection the construct was digested by NotI to release the P. berghei insert from its vector backbone. Parasites were transfected using the Nucleofector device (Amaxa Biosystems) as described previously 72, 73 . Integration of the DNA constructs into the chromosome was confirmed by PCR region flanking 5′ of the modified target locus and 3′ DHFR selection cassette (oligo 72; 5′-ACGTGCATGTGCGATTGTATTGGGT -3; oligo 9; 5′-CTTTGGTGACAGATACTAC -3′) and the absence of the wildtype locus (oligo 69 5′-ATGGGAAACTATACTTATATATATATTTTTTTCA -3′; oligo 70 5′-TTATAAATCAGAATTTTCTTCTCCTTC -3′). Two independent clones were obtained from two independent transfections, demonstrating statistically indistinguishable phenotypes. www.nature.com/scientificreports www.nature.com/scientificreports/ ΔPDI-Trans-Comp. For the complementation construct the clonal knockout line was injected into mice and mice were treated with 5-Fluorocytosine (5FC) nucleoside analog (Sigma) drinking water, 1.5 mg/ml to recycle the Hdhfr-yfcu marker. The subsequent marker free line was subjected to dilution cloning to achieve a pure population of marker free parasites. Following this the full length endogenous PBANKA_082030 gene was transfected on top using the artificial chromosome library clone mapping to PBANKA_082030 from PlasmoGEM (clone ID PbAC02-74d11) as described previously ( Figure S4) 39,73 . RT-PCR. P. berghei RNA was isolated from gametocyte deficient strain 2.33, activated or inactivated gametocytes, ookinetes and sporozoites from wild type P. berghei 2.34 strain using Trizol reagent (Invitrogen). cDNA synthesis was performed using Prime script kit from (Clonetech). PCR reactions were set up to amplify sections of PDI-Trans ORF (Forward 5′-ATGGGAAACTATACTTATATATATATTTTTTTCA-3′; and reverse 5′-CTACATATTTATCGACATCTCCAA-3′). The expected RT amplicon was 481 bp. The ubiquitously expressed α-tubulin gene PBANKA_0522700 was amplified for each sample to ensure amplifiability of cDNA from respective RNA samples (Forward, 5′-CCAGATGGTCAAATGCCC-3′; Reverse, 5′-CTGTGGTGATGGCCATGAAC-3′). The expected products were 435 bp (cDNA). Thirty RT-PCR cycles were carried out with denaturation for 1 min at 94 °C, annealing for 45 secs at 50 °C, and extension for 1.5 min at 68 °C, and products were visualized on a 0.8% agarose gel.
Direct feeding assay (DFA). Routine maintenance of P. berghei was carried out as described above. Prior to challenge, mice were PH treated, and 3 days later infected i.p. with 10 6 P. berghei ANKA 2.34 or ΔPDI-Trans parasites. Three-days post-infection, animals were anesthetized, and >50 female Anopheles stephensi mosquitoes allowed to blood feed on each mouse. Twenty-four hours later, unfed mosquitoes were removed. Mosquitoes were maintained on 8% (w/v) fructose, 0.05% (w/v) p-aminobenzoic acid at 19-22 °C and 50-80% relative humidity. Day 14 post-feeding, mosquito midguts were dissected and oocyst intensity and prevalence observed by standard phase microscopy and recorded. Reduction in oocyst intensity and prevalence in knockout mice were calculated with respect to wild type controls.
In Vitro ookinete conversion assay (IVOA). PH-treated mice were injected with 5 × 10 7 parasites i.p. On day 3 or 4 of infection, parasitaemia was counted on a Giemsa-stained tail blood smear and exflagellation of male gametocytes was checked by addition of a drop of exflagellation medium to a drop of tail blood. Hosts observed to have exflagellating parasites were exsanguinated by cardiac puncture and each 20 μl of blood taken up in 450 μl ookinete medium. Individual cultures were then added to pre-prepared 24 well plates (Nunc) and incubated for 24 h at 19 °C. Cultures were harvested after 24 h by centrifugation (500 × g, 5 min), washed once in 100 μl ookinete medium, and the pellet taken up in 50 μl ookinete medium containing Cy3-conjugated Pbs28 mAb clone 13.1 (1:500). Ookinetes and macrogametocytes were then immediately counted by fluorescence microscopy. Ookinete conversion rates were calculated as described previously 18 . In bacitracin experiments harvested parasites were added to ookinete medium containing a range of Bacitracin (Sigma Aldrich: #B0125) concentrations and either left in or washed and put into fresh medium 30 min after drug treatment. In antibody experiments harvested parasites were added to ookinete medium containing anti-PDI-Trans rabbit sera or anti-UPC10 (negative control). In each set of experiments results were collated from three separate experiments and inhibition expressed as the percentage reduction in ookinete conversion with respect to wild type parasites, samples with no bacitracin or the anti-UPC10 control.
Crosses. At day 3 post infection of phenylhydrazine treated mice, infected with parasites with either
ΔPDI-Trans, Δnek4, Δmap2 and wt were harvested by heart puncture and mixed at a 1:1 ratio in ookinete medium. After 24 h, ookinete conversion assays were performed by incubating samples with 13.1 antibody (antibody against Pb28 conjugated with Cy3). The proportion of ookinetes to all 13.1-positive cells (unfertilised macrogametes and ookinetes) was established, counting fields at 60 × magnification. Experiments were performed in biological triplicate 42,43 . PDI activity assay. PDI activity was measured in a microplate PDI inhibitor screening assay kit from Abcam (ab139480). Briefly, ΔPDI-Trans ΔPDI-Trans Comp and wild-type gametocytes were purified 42 . Non-activated gametocytes were Nycodenz purified in coelentrazine loading buffer and liberated from the red blood cell with lysis buffer before use. Both activated and non-activated gametocytes of each parasite line were used in the assay and the PDI-catalyzed reduction of insulin in the presence of Dithiothreitol resulting in the formation of insulin aggregates which bind avidly to the red-emitting fluorgenic PDI detection reagent were measured on Tecan, Infinite M200 Pro. The background media signal for each sample was subtracted and PDI activity was calculated as a percent relative to the positive control (human recombinant PDI). Bacitracin at 1 mM was used on human recombinant PDI as a control for a 50% reduction of activity as outlined by kit protocol. Experiments were performed in triplicate.
Standard membrane feeding assay (SMFA). P. berghei. Female An. stephensi (SDA 500 strain) were starved for twenty-four hours and then fed on heparinized P. berghei infected blood using standard membrane feeding methods [6460] . For each feed, 350 µl of P. berghei ANKA 2.34 infected blood containing asexual and sexual stages of the parasite was mixed with 150 µl of PBS containing either antibody to yield final concentration of 500 μg/ml or drug at 0.3, 1 and 3 mM. Mosquitoes were handled, maintained and analyzed as described above. Reductions in oocyst intensity and prevalence was calculated with respect to control feeds as described in 4 .
